Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AminoTher Pro (also known as AMINO-THER® PRO) is a medical nutrition product developed by Burg Pharma GmbH. It is a patented formulation containing a specific stoichiometric ratio of all 10 essential amino acids (EAAs) combined with three intermediate organic acids from the Krebs cycle (citric acid, malic acid, and succinic acid) and B vitamins (thiamine and pyridoxine). Classified as a food for special medical purposes (FSMP), it is indicated for the dietary management of protein malnutrition in acute and chronic diseases, sarcopenia, and exhaustion states such as post-viral fatigue and Long-COVID. The product is designed to support metabolic recovery and enhance mitochondrial energy production, and it can be administered orally or enterally under medical supervision.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AminoTher Pro.